Suppr超能文献

肿瘤提取物中基质金属蛋白酶-1组织抑制剂的蛋白水平作为胃癌患者预后和复发的标志物。

Protein levels of tissue inhibitor of metalloproteinase-1 in tumor extracts as a marker for prognosis and recurrence in patients with gastric cancer.

作者信息

Yoshikawa Takaki, Tsuburaya Akira, Kobayashi Osamu, Sairenji Motonori, Miyagi Yohei

机构信息

Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan.

出版信息

Gastric Cancer. 2006;9(2):106-13. doi: 10.1007/s10120-006-0362-y.

Abstract

BACKGROUND

Tissue inhibitor of metalloproteinase-1 (TIMP-1) correlates with tumor progression in patients with gastric cancer; however, the clinical significance of TIMP-1 as a marker for prognosis and recurrence has not been fully clarified.

METHODS

TIMP-1 protein was measured by an enzyme-linked immunosorbent assay in tumor samples from 86 patients who had undergone surgical resection. An intratumoral TIMP-1 value of 10.0 ng/mg protein or more was defined as positive. Patients were followed up for more than 5 years prospectively.

RESULTS

Thirty-one of the 86 patients (36.0%) were positive for TIMP-1. Kaplan-Meier curves for overall survival were significantly different between patients who were positive and those who were negative for TIMP-1. Univariate analysis of factors affecting overall survival showed that depth of tumor invasion; lymph node metastasis; peritoneal dissemination; lymphatic invasion; venous invasion; Lauren classification of histology; curability; and TIMP-1 were statistically significant. Stepwise multivariate analysis for overall survival demonstrated that depth of tumor invasion, nodal metastasis, peritoneal dissemination, and TIMP-1 remained independent prognostic factors. Kaplan-Meier curves for disease-free survival were significantly different between patients who were positive and those who were negative for TIMP-1. The incidence of recurrence was significantly higher in patients positive for TIMP-1 than in those who were negative for TIMP-1. The frequency at each site of recurrence was higher in patients positive for TIMP-1.

CONCLUSION

These results suggested that the protein concentration of TIMP-1 in the tumor extracts was a useful marker for overall survival, disease-free survival, and disease recurrence in patients with gastric cancer. Thus, tumor TIMP-1 may serve to identify a high-risk group, for whom optimal surgical and medical treatment can be given.

摘要

背景

基质金属蛋白酶-1组织抑制剂(TIMP-1)与胃癌患者的肿瘤进展相关;然而,TIMP-1作为预后和复发标志物的临床意义尚未完全阐明。

方法

采用酶联免疫吸附测定法检测86例行手术切除患者肿瘤样本中的TIMP-1蛋白。肿瘤内TIMP-1值≥10.0 ng/mg蛋白定义为阳性。对患者进行前瞻性随访5年以上。

结果

86例患者中有31例(36.0%)TIMP-1呈阳性。TIMP-1阳性和阴性患者的总生存Kaplan-Meier曲线有显著差异。影响总生存的因素单因素分析显示,肿瘤浸润深度、淋巴结转移、腹膜播散、淋巴管浸润、静脉浸润、Lauren组织学分类、可治愈性和TIMP-1具有统计学意义。总生存的逐步多因素分析表明,肿瘤浸润深度、淋巴结转移、腹膜播散和TIMP-1仍然是独立的预后因素。TIMP-1阳性和阴性患者的无病生存Kaplan-Meier曲线有显著差异。TIMP-1阳性患者的复发率显著高于阴性患者。TIMP-1阳性患者各复发部位的频率更高。

结论

这些结果表明,肿瘤提取物中TIMP-1的蛋白浓度是胃癌患者总生存、无病生存和疾病复发的有用标志物。因此,肿瘤TIMP-1可用于识别高危人群,以便给予最佳的手术和药物治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验